Assessing an eHealth Intervention on Quality of Life in Patients With Chronic Lymphocytic Leukemia and Myelodysplastic Syndromes: The MyPal Randomized Controlled Trial In the companion to this article ...
Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
While Enhertu (trastuzumab deruxtecan, T-DXd) is an established treatment for patients with HER2-low metastatic breast cancer (mBC), there has been limited information about how well it works for ...
Eastern Cooperative Oncology Group (ECOG) performance status (PS) is a key clinical variable for cancer treatment and research, but it is usually only recorded in unstructured form in the electronic ...
Please provide your email address to receive an email when new articles are posted on . Patient-reported physical function predicts which patients gain greatest survival benefit from daratumumab.
Researchers conducted a prospective, observational study to explore the impact of nutritional status prior to cancer treatment initiation and mortality risk.
Breast cancer is a complex disease with many types. Understanding the specific type and classification of the breast cancer you have is crucial so that you can fully participate as an informed partner ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results